Healthcare Analytical Testing Services Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

The global healthcare analytical testing services market size is projected to reach USD 11.2 billion by 2030 from USD 5.1 billion in 2020, at a CAGR of 12.4%.

Clear

Description

Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) – Global Forecast to 2030
Product Overview
Healthcare analytical testing services are widely used by pharmaceutical, biopharmaceutical, and medical device manufacturers that support throughout the stages of their drug development. These services provide support in the process of drug development started from discovery through clinical development or clinical trials to commercial use.
Market Overview
The global healthcare analytical testing services market size is projected to reach USD 11.2 billion by 2030 from USD 5.1 billion in 2020, at a CAGR of 12.4%. In the current global scenario-where the focus on biologics and biosimilars has risen-it is expected that the benefits of advanced healthcare analytical testing services will ensure their greater adoption. The increasing demand for specialized testing services, the number of clinical trials, and the acceptance of the QbD approach in pharmaceutical research and manufacturing are other factors driving the growth of this market.
The batch-release testing segment is projected to grow at the highest CAGR during the forecast period
Within the type segment, the market is segmented into bioanalytical testing services, physical characterization services, method development & validation services, raw material testing services, batch-release testing services, stability testing services, microbial testing services, and environmental monitoring services. The batch-release testing segment is projected to grow at the highest CAGR during the forecast period. Within the batch-release testing services segment, the dissolution testing services market is projected to grow at the highest growth rate during the forecast period.
Pharmaceutical & biopharmaceutical companies hold the largest share in the market
Market Dynamics
The growing outsourcing of analytical testing by pharmaceutical companies, focus on analytical testing of biologics and biosimilars, increasing acceptance of the quality-by-design approach in pharma research and manufacturing are some of the factors behind the growth of the healthcare analytical testing services market in the forecast period of 2020 to 2027. On the other hand, the increasing demand for specialized analytical testing services will create several opportunities that will lead to the growth of the healthcare analytical testing services market in the above mentioned period.
Dearth of skilled professionals will act as a restraint to the growth of the healthcare analytical testing services market in the above mentioned period. But, the necessity to improve the sensitivity of bioanalytical methods will act as a challenge to the healthcare analytical testing services market growth.

North America holds the largest share in the healthcare analytical testing services market, by region
North America held the largest share in the healthcare analytical testing services market in 2019. This dominance of North America in this market is due to the presence of many pharmaceutical and biopharmaceutical companies, high investments and rising focus on the biosimilars & biologics segment, and high allocation to R&D. The Asia Pacific market is expected to register the highest growth during the forecast period, primarily due to the lower production costs and growing favorability of the regulatory environment.
Key market players
The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), LabCorp (US), SGS (Switzerland), Charles River Laboratories (US), WuXi PharmaTech (China), PPD (US), Element Materials Technology (UK), Pace Analytical (US), Intertek (UK), Merck KGAA (Germany), Source BioScience (UK), Almac Group (Ireland), ICON (Ireland), Frontage Labs (US), STERIS PLC (US), PRA Health Sciences (US), Syneos Health (US), Medpace Holdings (US), LGC Limited (UK), and Anacura (Belgium).
By Type
• Bioanalytical Testing Services
o Cell-based Assays
o Virology Testing
o Immunogenicity & Neutralizing Antibody Testing
o Biomarker Testing
o Pharmacokinetic Testing
o Other Bioanalytical Testing Services
• Physical Characterization Services
o Laser Particle Size Analysis
o Thermal Analysis
o Image Analysis
o Surface Area Analysis
o Other Physical Characterization Services
• Method Development & Validation Services
o Extractable & Leachable Method Development & Validation;
o Process Impurity Method Development & Validation;
o Stability-indicating Method Validation
o Cleaning Validation
o Analytical Standard Characterization
o Technical Consulting
o Other Method Development & Validation Services
• Raw Material Testing Services
o Complete Compendial Testing
o Heavy Metal Testing
o Container Testing
o Karl Fischer Analysis
o Wet Chemistry Analysis
o Other Raw Material Testing Services
• Batch-release Testing Services
o Dissolution Testing
o Elemental Impurity Testing
o Disintegration Testing
o Hardness Testing
o Friability Testing
o Other Batch-release Testing Services
• Stability Testing
o Drug Substance Stability Testing
o Formulation Evaluation Stability Testing
o Accelerated Stability Testing
o Photostability Testing
o Comparative Stability Testing
o Other Stability Testing Services
• Microbial Testing Services
o Microbial Limit Testing
o Sterility Testing
o Endotoxin Testing
o Preservative Efficacy Testing
o Water Testing
o Other Microbial Testing Services
• Environmental Monitoring Services
o Air Testing
o Wastewater/ETP Testing
o Other Environmental Monitoring Services
By End User
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Contract Research Organizations

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Global Healthcare Analytical Testing Services Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Healthcare Analytical Testing Services Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Healthcare Analytical Testing Services Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Healthcare Analytical Testing Services Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
12.2.1. Bioanalytical Testing Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Physical Characterization Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Method Development & Validation Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Raw Material Testing Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.5. Batch-release Testing Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.6. Stability Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.7. Microbial Testing Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.8. Environmental Monitoring Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End User: Market Share (2020-2030F)
12.3.1. Pharmaceutical & Biopharmaceutical Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Medical Device Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Contract Research Organizations, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13 Company Profile
13.1. Eurofins Scientific (Luxembourg)
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. LabCorp (US)
13.3. SGS (Switzerland)
13.4. Charles River Laboratories (US)
13.5. WuXi PharmaTech (China)
13.6. PPD (US)
13.7. Element Materials Technology (UK)
13.8. Pace Analytical (US)
13.9. Intertek (UK)
13.10. Merck KGAA (Germany)
13.11. Source BioScience (UK)
13.12. Almac Group (Ireland)
13.13. Other Prominent Players

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.